Ravi Vij, MD, MBA

Bone Marrow Transplant Specialist, Medical Oncologist

Primary Academic Title

Professor of Medicine, Division of Oncology, Section of Bone Marrow Transplantation, Washington University School of Medicine

Clinical Expertise

As a member of our leukemia and myelodysplastic syndromes specialist teams, Dr. Vij cares for patients diagnosed with leukemia and lymphoma through treatment and recovery. Learn more about Dr. Vij and the Blood and Marrow Transplant Program at Siteman.

Research Interest

Clinical interest in stem-cell transplantation and the management of hematologic malignancy. I lead a multi-disciplinary research program focused on treatment of multiple myeloma.

Education

1989: MBBS, Maulana Azad Medical College, New Delhi, India

Board Certification

1996: American Board of Internal Medicine, Internal Medicine
1999: American Board of Internal Medicine, Medical Oncology
2000: American Board of Internal Medicine, Hematology

Selected Research Publications

First-in-Humans Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging.

Laforest R, Ghai A, Fraum TJ, [...] Vij R, [...] Dehdashti F
J Nucl Med 2023

The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.

Mei M, Pillai R, Kim S, [...] Vij R, [...] Nakamura R
Haematologica 2023

A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma.

D'Souza A, Shah N, Rodriguez C, [...] Vij R, Kumar S
J Clin Oncol 2022

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells.

O'Neal J, Ritchey JK, Cooper ML, [...] Vij R, DiPersio JF
Leukemia 2022

LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma.

Mateos MV, Weisel K, De Stefano V, [...] Vij R, [...] Moreau P
Leukemia 2022

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.

Guru Murthy GS, Kim S, Hu ZH, [...] Vij R, [...] Saber W
JAMA Oncol 2022

Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy.

Alhallak K, Sun J, Wasden K, [...] Vij R, [...] Azab AK
Leukemia 2021

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Lazaryan A, Dolan M, Zhang MJ, [...] Vij R, [...] Weisdorf D
Haematologica 2021

Evolving Paradigms of Therapy for Multiple Myeloma: State of the Art and Future Directions.

Goldsmith SR, Vij R
JCO Oncol Pract 2021

Co-evolution of tumor and immune cells during progression of multiple myeloma.

Liu R, Gao Q, Foltz SM, [...] Vij R, Ding L
Nat Commun 2021

VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival.

Fontana F, Scott MJ, Allen JS, [...] Vij R, [...] Lanza G
Clin Cancer Res 2021

Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma.

Dimopoulos M, Bringhen S, Anttila P, [...] Vij R
Blood 2021

A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma.

Mikhael J, Richter J, Vij R, [...] Martin T
Leukemia 2020

Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma.

Federico C, Alhallak K, Sun J, [...] Vij R, [...] Azab AK
Nat Commun 2020

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma.

Jasielec JK, Kubicki T, Raje N, Vij R, [...] Jakubowiak AJ
Blood 2020

Contact Information

Washington University Medical Campus

4921 Parkview Place
Saint Louis, MO 63110

Phone Numbers

Appointments: (314) 747-7222
Toll Free: (800) 600-3606

Request an appointment